Nutritional supplement market growing

Article

The eyecare nutritional supplement market is worth $43.4 million and is projected to grow to $87.4 million within five years, according to research by Frost & Sullivan.

The eyecare nutritional supplement market is worth $43.4 million and is projected to grow to $87.4 million within five years, according to research by Frost & Sullivan.

According to Frost & Sullivan, the impending rapid growth in the market is due to the ageing of the "baby boomer" generation, as well as the recent developments in nutritional supplements for conditions commonly associated with either lifestyle or advanced age, including glaucoma and age-related macular degeneration.

Although nutritional supplements for eye conditions are a relatively new concept, the products Frost & Sullivan assessed included antioxidants such as lutein, beta-carotene, zeaxanthin, astaxanthin, and bilberry.

Despite barriers such as increasing price erosion and variation in international regulations, increased consumer awareness and more validated research into nutritional supplements' efficacy will result in great potential for growth in the market, Frost & Sullivan concluded.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
© 2025 MJH Life Sciences

All rights reserved.